Search for: "AMGEN INC." Results 301 - 320 of 704
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
8 Nov 2015, 9:20 pm by Patent Docs
Amgen Inc. et al. v. [read post]
18 Oct 2015, 10:00 pm by Courtenay C. Brinckerhoff
The Federal Circuit denied the petitions for rehearing en banc filed in Amgen Inc. v. [read post]
18 Oct 2015, 10:00 pm by Courtenay C. Brinckerhoff
The Federal Circuit denied the petitions for rehearing en banc filed in Amgen Inc. v. [read post]
5 Oct 2015, 8:19 am
  Just look at the FDA’s “reference 5” − Defendant’s [FDA’s] Memorandum of Points & Authorities In Support of Motion to Dismiss or Summary Judgment, Allergan Inc., v. [read post]
10 Sep 2015, 8:29 am by John Jascob
Current and former employees of Amgen, Inc. filed a class action under ERISA after their employer-sponsored pension plans lost significant value due to concerns about the safety of certain Amgen drugs. [read post]
7 Sep 2015, 8:09 am by Gregory J. Brod
According to the article and assorted legal actions against the companies, drug companies including Abbott Laboratories and Amgen, Inc. paid millions of dollars in kickbacks and other financial incentives to encourage distributing pharmacies to push certain medications. [read post]
26 Aug 2015, 10:00 pm by Courtenay C. Brinckerhoff
Amgen has filed a complaint under the Biologics Price Competition and Innovation Act (BPCIA), asserting that a biosimilar application filed by Apotex, Inc. infringes two of its patents. [read post]
30 Jul 2015, 9:50 am
 That is what today's decision addresses.Appeal to the Supreme CourtThe Court of Appeal has refused leave for Smith & Nephew to appeal to the Supreme Court, because it considered that there is no significant point of general public importance at stake, since it has done no more than apply the established principles of claim construction from Kirin Amgen (Kirin Amgen Inc v Hoechst Marion Roussel Ltd [2004] UKHL 46, [2005] RPC 9) to the case before it. [read post]
23 Jul 2015, 9:59 pm by Patent Docs
By Andrew Williams -- As we have been reporting this week, the Federal Circuit handed down its decision in Amgen Inc. v. [read post]
30 May 2015, 11:03 am by Lawrence B. Ebert
The CAFC will interpret parts of the Biologic Price Competition and Innovation Act (BPCIA) in the case Amgen v. [read post]
12 May 2015, 3:30 pm by James Galvin
Inc. 90271J739 UBS Trigger Phoenix Autocallable Optimization Securities linked to Genworth Financial, Inc. 90271J721 UBS Trigger Phoenix Autocallable Optimization Securities linked to BlackRock, Inc. 90271J689 UBS Trigger Phoenix Autocallable Optimization Securities linked to Baidu, Inc. 90271J671 UBS Trigger Phoenix Autocallable Optimization Securities linked to Bank of America 90271J663 UBS Trigger Phoenix Autocallable Optimization Securities linked to U.S. [read post]
12 May 2015, 3:26 pm by James Galvin
The following is a list of some of the UBS Reverse Convertible Notes offered: CUSIP Issuer Product Name 90261J426 UBS Yield Optimization Notes with Contingent Protection linked to Starbucks Corp. 90261J434 UBS Yield Optimization Notes with Contingent Protection linked to Intel Corp. 90261J459 UBS Yield Optimization Notes with Contingent Protection linked to Apple, Inc. 90261J319 UBS Yield Optimization Notes with Contingent Protection linked linked to Occidental Petroleum Corp.… [read post]
12 May 2015, 2:04 pm by James Galvin
The following is a list of some of the Barclays Reverse Convertible Notes offered: CUSIP Issuer Product Name 06740JJL5 Barclays Reverse Convertible Notes linked to Wells Fargo & Co. 06740JTD2 Barclays Reverse Convertible Notes linked to Wells Fargo & Co. 06740PGR1 Barclays Reverse Convertible Notes linked to Wells Fargo & Co. 06741JZQ5 Barclays Reverse Convertible Notes linked to 3D Systems Corp 06741J5M7 Barclays Reverse Convertible Notes linked to 3D Systems Corp 06741J3Y3 Barclays… [read post]